Marcio Lourenço Rodrigues

Instituição:

Universidade Federal do Rio de Janeiro

Centro:

PR-4 Pró-Reitoria de Pessoal

Unidade:

Divisão de Pessoal

Departamento:

Cessão

ORCID:

https://orcid.org/0000-0002-6081-3439


Formação:
  • Albert Einstein College of Medicine

    | Pós-Doutorado | 2007 - 2007
  • Albert Einstein College of Medicine

    Patogênese fúngica - Estágio júnior | Especialização | 2005 - 2005
  • Universidade Federal de São Paulo

    | Pós-Doutorado | 2001 - 2002
  • Universidade Federal do Rio de Janeiro

    Ciências (Microbiologia) | Doutorado | 1997 - 2000
  • Universidade Federal do Rio de Janeiro

    Ciências (Microbiologia) | Mestrado | 1996 - 1997
  • Universidade Federal do Rio de Janeiro

    Farmacêutico | Graduação | 1992 - 1995
Laboratórios:
Nenhum laboratório cadastrado
Nuvens de Palavras:
Artigos:

(99.50% artigos com DOI)

Titulo DOI Ano
Funding for research on cryptococcal disease: an analysis based on the G-finder report 10.1186/s43008-023-00133-6 2024
Proteomics reveals that the antifungal activity of fenbendazole against Cryptococcus neoformans requires protein kinases 10.1016/j.ijantimicag.2024.107157 2024
Comparison of the antifungal activity of the pyrimidine analogs flucytosine and carmofur against human-pathogenic dematiaceous fungi 10.1093/mmy/myae029 2024
Comprehensive characterization of extracellular vesicles produced by environmental (Neff) and clinical (T4) strains of Acanthamoeba castellanii 10.1128/msystems.01226-23 2024
Protocol for separation of fungal extracellular vesicles using ultracentrifugation from solid medium cultures 10.1016/j.xpro.2024.103069 2024
Morphological and pathogenic investigation of the emerging fungal threat 10.1128/spectrum.00863-24 2024
Extracellular Vesicles from Scedosporium apiospermum Mycelial Cells: Implication for Fungal-Host Interplays 10.3390/jof10040277 2024
A tribute to a man of science: lessons from Professor Luiz R. Travassos (1938-2020) 10.1007/s42770-023-00908-4 2023
Professor Luiz R. Travassos and the study of surface structures of fungal pathogens 10.1007/s42770-023-00916-4 2023
Organoselenium Has a Potent Fungicidal Effect on Cryptococcus neoformans and Inhibits the Virulence Factors 10.1128/aac.00759-22 2023
A close look into the composition and functions of fungal extracellular vesicles produced by phytopathogens 10.1094/MPMI-09-22-0184-FI 2023
Recognition of fungal priority pathogens: What next? 10.1371/journal.pntd.0011136 2023
Mebendazole Inhibits Histoplasma capsulatum In Vitro Growth and Decreases Mitochondrion and Cytoskeleton Protein Levels 10.3390/jof9030385 2023
Coregulation of extracellular vesicle production and fluconazole susceptibility in 10.1128/mbio.00870-23 2023
Repurposing Benzimidazoles against Causative Agents of Chromoblastomycosis: Albendazole Has Superior In Vitro Activity Than Mebendazole and Thiabendazole 10.3390/jof9070753 2023
More complicated than it seems: The diversity of cryptococcal glucuronoxylomannan 10.1371/journal.ppat.1011521 2023
The characterization of RNA-binding proteins and RNA metabolism-related proteins in fungal extracellular vesicles 10.3389/fcimb.2023.1247329 2023
The multiple frontiers in the study of extracellular vesicles produced by fungi 10.1016/j.micinf.2023.105233 2023
Brazilian Science: towards extinction? 10.1590/0074-02760210357 2022
From fundamental biology to the search for innovation: the story of fungal extracellular vesicles 10.1016/j.ejcb.2022.151205 2022
Extracellular Vesicles Regulate Biofilm Formation and Yeast-to-Hypha Differentiation in Candida albicans 10.1128/mbio.00301-22 2022
Screening of the Pandemic Response Box Reveals an Association between Antifungal Effects of MMV1593537 and the Cell Wall of Cryptococcus neoformans, Cryptococcus deuterogattii, and Candida auris 10.1128/spectrum.00601-22 2022
Article-processing charges as a barrier for science in low-to-medium income regions 10.1590/0074-02760220064 2022
Identification of 4 compounds from the Pharmakon library with antifungal activity against Candida auris and species of Cryptococcus 10.1093/mmy/myac033 2022
Fungal Extracellular Vesicles Are Involved in Intraspecies Intracellular Communication 10.1128/mbio.03272-21 2022
Extracellular Vesicle Formation in Cryptococcus deuterogattii Impacts Fungal Virulence and Requires the NOP16 Gene 10.1128/iai.00232-22 2022
Extracellular Vesicles in Diseases, Host-pathogen Interaction and Therapeutic Applications 10.3389/fcimb.2022.1010008 2022
Caspofungin Affects Extracellular Vesicle Production and Cargo in Candida auris 10.3390/jof8100990 2022
Cryptococcus neoformans releases proteins during intracellular residence that affect the outcome of the fungal-macrophage interaction. 10.1093/femsml/uqac015 2022
Histoplasma capsulatum Glycans From Distinct Genotypes Share Structural and Serological Similarities to Cryptococcus neoformans Glucuronoxylomannan 10.3389/fcimb.2020.565571 2021
The benefits of exporting: engineered extracellular vesicles as promising vaccine candidates against enteric fever 10.1128/IAI.00001-21 2021
Phytotoxic Tryptoquialanines Produced In Vivo by Penicillium digitatum Are Exported in Extracellular Vesicles 10.1128/mbio.03393-20 2021
Antifungal activity of Acylhydrazone derivatives against spp. 10.1128/AAC.02593-20 2021
Small Molecule Analysis of Extracellular Vesicles Produced by Cryptococcus gattii: Identification of a Tripeptide Controlling Cryptococcal Infection in an Invertebrate Host Model 10.3389/fimmu.2021.654574 2021
Population genomic analysis of Brazilian isolates reveals an African type subclade distribution 10.1093/g3journal/jkab107 2021
The paradoxical and still obscure properties of fungal extracellular vesicles 10.1016/j.molimm.2021.04.009 2021
ExVe: The knowledge base of orthologous proteins identified in fungal extracellular vesicles 10.1016/j.csbj.2021.04.031 2021
Omics Approaches for Understanding Biogenesis, Composition and Functions of Fungal Extracellular Vesicles 10.3389/fgene.2021.648524 2021
Repurposing benzimidazoles to fight Cryptococcus 10.1016/j.fbr.2021.04.002 2021
Analysis of Cryptococcal Extracellular Vesicles: Experimental Approaches for Studying Their Diversity Among Multiple Isolates, Kinetics of Production, Methods of Separation, and Detection in Cultures of Titan Cells 10.1128/Spectrum.00125-21 2021
extracellular vesicles properties and their use as vaccine platforms 10.1002/jev2.12129 2021
Screening of Chemical Libraries for New Antifungal Drugs against Aspergillus fumigatus Reveals Sphingolipids Are Involved in the Mechanism of Action of Miltefosine 10.1128/mBio.01458-21 2021
Comparative Molecular and Immunoregulatory Analysis of Extracellular Vesicles from Candida albicans and Candida auris 10.1128/msystems.00822-21 2021
Monoclonal antibodies against cell wall chitooligomers as accessory tools for the control of cryptococcosis 10.1128/AAC.01181-21 2021
Transcriptional and translational landscape of Candida auris in response to caspofungin 10.1016/j.csbj.2021.09.007 2021
P-Type ATPase Apt1 of the Fungal Pathogen Cryptococcus neoformans Is a Lipid Flippase of Broad Substrate Specificity 10.3390/jof7100843 2021
Cellular and Extracellular Vesicle RNA Analysis in the Global Threat Fungus 10.1128/Spectrum.01538-21 2021
Fungal diseases as neglected pathogens: A wake-up call to public health officials 10.1371/journal.pntd.0007964 2020
Scanning electron microscopy and machine learning reveal heterogeneity in capsular morphotypes of the human pathogen Cryptococcus spp. 10.1038/s41598-020-59276-w 2020
Erg6 affects membrane composition and virulence of the human fungal pathogen Cryptococcus neoformans 10.1016/j.fgb.2020.103368 2020
A screening of the MMV Pathogen Box® reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis 10.1371/journal.pone.0229630 2020
Media Matters! Alterations in the loading and release of extracellular vesicles in response to different nutritional milieus 10.1111/cmi.13217 2020
Fenbendazole controls in vitro growth, virulence potential and animal infection in the Cryptococcus model 10.1128/aac.00286-20 2020
Extracellular vesicles in fungi: past, present and future perspectives 10.3389/fcimb.2020.00346 2020
Protective effect of fungal extracellular vesicles against murine candidiasis. 10.1111/cmi.13238 2020
Hypervirulence and cross-resistance to a clinical antifungal are induced by an environmental fungicide in Cryptococcus gattii 10.1016/j.scitotenv.2020.140135 2020
Participation of Zip3, a ZIP domain-containing protein, in stress response and virulence in Cryptococcus gattii 10.1016/j.fgb.2020.103438 2020
Characterization of Extracellular Vesicles Produced by Protoplasts 10.1128/mSphere.00476-20 2020
Pathogenic Delivery: The Biological Roles of Cryptococcal Extracellular Vesicles 10.3390/pathogens9090754 2020
Pyrifenox, an ergosterol inhibitor, differentially affects Cryptococcus neoformans and Cryptococcus gattii 10.1093/mmy/myz132 2020
The Still Underestimated Problem of Fungal Diseases Worldwide 10.3389/fmicb.2019.00214 2019
Host membrane glycosphingolipids and lipid microdomains facilitate Histoplasma capsulatum internalization by macrophages. 10.1111/cmi.12976 2019
A Novel Protocol for the Isolation of Fungal Extracellular Vesicles Reveals the Participation of a Putative Scramblase in Polysaccharide Export and Capsule Construction in 10.1128/mSphere.00080-19 2019
Extracellular Vesicle-Mediated RNA Release in Histoplasma capsulatum 10.1128/msphere.00176-19 2019
Glucuronoxylomannan and Sterylglucoside Are Required for Host Protection in an Animal Vaccination Model 10.1128/mBio.02909-18 2019
Exploiting Lipids to Develop Anticryptococcal Vaccines 10.1007/s40475-019-00178-x 2019
Extracellular vesicles as vehicles for the delivery of biologically active fungal molecules 10.2174/1389203720666190529124055 2019
Comparison of the RNA Content of Extracellular Vesicles Derived from Paracoccidioides brasiliensis and Paracoccidioides lutzii 10.3390/cells8070765 2019
Deciphering Fungal Extracellular Vesicles: From Cell Biology to Pathogenesis 10.1007/s40588-019-00128-1 2019
Polysaccharide diversity in VNI isolates of Cryptococcus neoformans from Roraima, Northern Brazil 10.1016/j.funbio.2019.06.003 2019
Fungal Extracellular Vesicles as Potential Targets for Immune Interventions 10.1128/msphere.00747-19 2019
Role of lipid transporters in fungal physiology and pathogenicity 10.1016/j.csbj.2019.09.001 2019
The putative flippase Apt1 is required for intracellular membrane architecture and biosynthesis of polysaccharide and lipids in Cryptococcus neoformans 10.1016/j.bbamcr.2017.12.007 2018
Warfare and defense: The host response to Cryptococcus infection 10.1016/j.fbr.2017.09.002 2018
Fungal extracellular vesicles: modulating host-pathogen interactions by both the fungus and the host 10.1016/j.micinf.2018.01.011 2018
A Predicted Mannoprotein Participates in Capsular Structure 10.1128/mSphere.00023-18 2018
Neglected disease, neglected populations: the fight against Cryptococcus and cryptococcosis 10.1590/0074-02760180111 2018
A UBI 31-38 Peptide-Coumarin Conjugate: Photophysical Features, Imaging Tracking And Synergism With Amphotericin B Against Cryptococcus 10.2174/1568026618666180221113137 2018
Searching for a change: The need for increased support for public health and research on fungal diseases 10.1371/journal.pntd.0006479 2018
Lack of chitin synthase genes impacts capsular architecture and cellular physiology in Cryptococcus neoformans 10.1016/j.tcsw.2018.05.002 2018
Golgi Reassembly and Stacking Protein (GRASP) Participates in Vesicle-Mediated RNA Export in Cryptococcus Neoformans 10.3390/genes9080400 2018
The Multifunctional Fungal Ergosterol 10.1128/mBio.01755-18 2018
A glucuronoxylomannan-like glycan produced by Trichosporon mucoides 10.1016/j.fgb.2018.09.009 2018
A two-way road: novel roles for fungal extracellular vesicles 10.1111/mmi.14095 2018
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries 10.1016/s1473-3099(18)30493-6 2018
Future perspectives for cryptococcosis treatment 10.1080/13543776.2018.1503252 2018
Pharmacological inhibition of pigmentation in Cryptococcus 10.1093/femsyr/foy119 2018
Bibliometric Indicators of the Zika Outbreak 10.1371/journal.pntd.0005132 2017
Phosphorus-rich structures and capsular architecture in Cryptococcus neoformans 10.2217/fmb-2017-0060 2017
The Anti-helminthic Compound Mebendazole Has Multiple Antifungal Effects against Cryptococcus neoformans 10.3389/fmicb.2017.00535 2017
Analysis of multiple components involved in the interaction between Cryptococcus neoformans and Acanthamoeba castellanii 10.1016/j.funbio.2017.04.002 2017
Changes in glucosylceramide structure affect virulence and membrane biophysical properties of Cryptococcus neoformans 10.1016/j.bbamem.2017.08.017 2017
Characterization of the antifungal functions of a WGA-Fc (IgG2a) fusion protein binding to cell wall chitin oligomers 10.1038/s41598-017-12540-y 2017
Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects 10.1038/s41467-017-02126-7 2017
What Is New? Recent Knowledge on Fungal Extracellular Vesicles 10.1007/s12281-017-0293-6 2017
Enhanced virulence of Histoplasma capsulatum through transfer and surface incorporation of glycans from Cryptococcus neoformans during co-infection 10.1038/srep21765 2016
Funding and Innovation in Diseases of Neglected Populations: The Paradox of Cryptococcal Meningitis 10.1371/journal.pntd.0004429 2016
The Brazilian Dilemma: Increased Scientific Production and High Publication Costs during a Global Health Crisis and Major Economic Downturn 10.1128/mBio.00907-16 2016
Potential Roles of Fungal Extracellular Vesicles during Infection 10.1128/mSphere.00099-16 2016
Extracellular Vesicle-Associated Transitory Cell Wall Components and Their Impact on the Interaction of Fungi with Host Cells 10.3389/fmicb.2016.01034 2016
New structural insights into Golgi Reassembly and Stacking Protein (GRASP) in solution 10.1038/srep29976 2016
The putative autophagy regulator Atg7 affects the physiology and pathogenic mechanisms of Cryptococcus neoformans 10.2217/fmb-2016-0090 2016
The benefits of scientific mobility and international collaboration 10.1093/femsle/fnw247 2016
Virulence Factors as Targets for Anticryptococcal Therapy 10.3390/jof2040029 2016
Extracellular vesicle-mediated export of fungal RNA 10.1038/srep07763 2015
Compositional and immunobiological analyses of extracellular vesicles released by C andida albicans 10.1111/cmi.12374 2015
EVpedia: a community web portal for extracellular vesicles research 10.1093/bioinformatics/btu741 2015
Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids 10.1128/mBio.00647-15 2015
Pathogenic diversity amongst serotype C VGIII and VGIV Cryptococcus gattii isolates 10.1038/srep11717 2015
Fungal colonization of the brain: anatomopathological aspects of neurological cryptococcosis 10.1590/0001-3765201520140704 2015
Traveling into Outer Space: Unanswered Questions about Fungal Extracellular Vesicles 10.1371/journal.ppat.1005240 2015
The Einstein-Brazil Fogarty: A decade of synergy 10.1590/S1517-838246420140975 2015
Synthesis and Biological Properties of Fungal Glucosylceramide 10.1371/journal.ppat.1003832 2014
The impact of proteomics on the understanding of functions and biogenesis of fungal extracellular vesicles 10.1016/j.jprot.2013.04.001 2014
glucuronoxylomannan fractions of different molecular masses are functionally distinct 10.2217/fmb.13.163 2014
Hemoglobin Uptake by Paracoccidioides spp. Is Receptor-Mediated 10.1371/journal.pntd.0002856 2014
The vacuolar-sorting protein Snf7 is required for export of virulence determinants in members of the Cryptococcus neoformans complex. 10.1038/srep06198 2014
Role of the Apt1 Protein in Polysaccharide Secretion by Cryptococcus neoformans 10.1128/EC.00273-13 2014
Where Do They Come from and Where Do They Go: Candidates for Regulating Extracellular Vesicle Formation in Fungi 10.3390/ijms14059581 2013
Vesicular mechanisms of traffic of fungal molecules to the extracellular space 10.1016/j.mib.2013.04.002 2013
The calcium transporter Pmc1 provides Ca 2+ tolerance and influences the progression of murine cryptococcal infection 10.1111/febs.12458 2013
Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis 10.1016/j.fgb.2013.04.005 2013
The heat shock protein (Hsp) 70 of Cryptococcus neoformans is associated with the fungal cell surface and influences the interaction between yeast and host cells 10.1016/j.fgb.2013.08.005 2013
Capsules from Pathogenic and Non-Pathogenic Cryptococcus spp. Manifest Significant Differences in Structure and Ability to Protect against Phagocytic Cells 10.1371/journal.pone.0029561 2012
Surface Architecture Of Fungal Pathogens 10.3389/fmicb.2012.00080 2012
Research trends on pathogenic species in the last 20 years: a global analysis with focus on Brazil 10.2217/fmb.11.162 2012
Unravelling Secretion in Cryptococcus neoformans: More than One Way to Skin a Cat 10.1007/s11046-011-9468-9 2012
In good company: association between fungal glycans generates molecular complexes with unique functions 10.3389/fmicb.2012.00249 2012
Chitin-Like Molecules Associate with Cryptococcus neoformans Glucuronoxylomannan To Form a Glycan Complex with Previously Unknown Properties 10.1128/EC.00001-12 2012
A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan 10.1016/j.fgb.2012.09.002 2012
Antibody Binding to Cryptococcus neoformans Impairs Budding by Altering Capsular Mechanical Properties 10.4049/jimmunol.1202324 2012
The GATA-type transcriptional activator Gat1 regulates nitrogen uptake and metabolism in the human pathogen Cryptococcus neoformans 10.1016/j.fgb.2010.07.011 2011
Agglutination of Histoplasma capsulatum by IgG Monoclonal Antibodies against Hsp60 Impacts Macrophage Effector Functions 10.1128/IAI.00673-10 2011
Calcium signaling components in the human pathogen 10.4161/cib.4.2.14271 2011
Glucuronoxylomannan from Cryptococcus neoformans Down-regulates the Enzyme 6-Phosphofructo-1-kinase of Macrophages 10.1074/jbc.M110.177030 2011
Role for Golgi reassembly and stacking protein (GRASP) in polysaccharide secretion and fungal virulence 10.1111/j.1365-2958.2011.07686.x 2011
Fungal Polysaccharides: Biological Activity Beyond the Usual Structural Properties 10.3389/fmicb.2011.00171 2011
Fungal Glucosylceramides: From Structural Components to Biologically Active Targets of New Antimicrobials 10.3389/fmicb.2011.00212 2011
Effects of microplusin, a copper-chelating antimicrobial peptide, against Cryptococcus neoformans 10.1111/j.1574-6968.2011.02386.x 2011
Vesicular transport systems in fungi 10.2217/fmb.11.112 2011
Chronological Aging Is Associated with Biophysical and Chemical Changes in the Capsule of Cryptococcus neoformans 10.1128/IAI.05789-11 2011
Extracellular Vesicles from Cryptococcus neoformans Modulate Macrophage Functions 10.1128/IAI.01171-09 2010
Characterization of Yeast Extracellular Vesicles: Evidence for the Participation of Different Pathways of Cellular Traffic in Vesicle Biogenesis 10.1371/journal.pone.0011113 2010
Biogenesis of extracellular vesicles in yeast: Many questions with few answers 10.4161/cib.3.6.12756 2010
Paracoccidioides brasiliensis Enolase Is a Surface Protein That Binds Plasminogen and Mediates Interaction of Yeast Forms with Host Cells 10.1128/IAI.00221-10 2010
Biochemical characterization of an ecto-ATP diphosphohydrolase activity in Candida parapsilosis?and its possible role in adenosine acquisition and pathogenesis 10.1111/j.1567-1364.2010.00641.x 2010
Immunomodulatory Effects of Serotype B Glucuronoxylomannan from Cryptococcus gattii Correlate with Polysaccharide Diameter 10.1128/IAI.00111-10 2010
The Vacuolar Ca2+ Exchanger Vcx1 Is Involved in Calcineurin-Dependent Ca2+ Tolerance and Virulence in Cryptococcus neoformans 10.1128/EC.00114-10 2010
The Capsule of the Fungal Pathogen Cryptococcus neoformans 10.1016/S0065-2164(09)01204-0 2009
Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules 10.1073/pnas.0808995106 2009
Vesicular transport across the fungal cell wall 10.1016/j.tim.2008.12.005 2009
The Elastic Properties of the Cryptococcus neoformans Capsule 10.1016/j.bpj.2009.04.043 2009
Structural and functional properties of the Trichosporon asahii glucuronoxylomannan 10.1016/j.fgb.2009.03.003 2009
Role for Chitin and Chitooligomers in the Capsular Architecture of Cryptococcus neoformans 10.1128/EC.00142-09 2009
Cryptococcus neoformans cryoultramicrotomy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronoxylomannan 10.1016/j.fgb.2009.09.001 2009
Vesicle-associated melanization in Cryptococcus neoformans 10.1099/mic.0.032854-0 2009
The still obscure attributes of cryptococcal glucuronoxylomannan 10.3109/13693780902788621 2009
Novel Role of Sphingolipid Synthesis Genes in Regulating Giardial Encystation 10.1128/IAI.00116-08 2008
Vesicular transport in Histoplasma capsulatum : an effective mechanism for trans-cell wall transfer of proteins and lipids in ascomycetes 10.1111/j.1462-5822.2008.01160.x 2008
A role for vesicular transport of macromolecules across cell walls in fungal pathogenesis 10.4161/cib.1.1.6639 2008
Sophisticated Functions for a Simple Molecule: The Role of Glucosylceramides in Fungal Cells 10.4137/LPI.S1014 2008
In Vitro Activity of the Antifungal Plant Defensin RsAFP2 against Candida Isolates and Its In Vivo Efficacy in Prophylactic Murine Models of Candidiasis 10.1128/AAC.00448-08 2008
Capsular Localization of the Cryptococcus neoformans Polysaccharide Component Galactoxylomannan 10.1128/EC.00331-08 2008
Vesicular Trans-Cell Wall Transport in Fungi: A Mechanism for the Delivery of Virulence-Associated Macromolecules? 10.4137/LPI.S1000 2008
Binding of Glucuronoxylomannan to the CD14 Receptor in Human A549 Alveolar Cells Induces Interleukin-8 Production 10.1128/CVI.00296-06 2007
An ectophosphatase activity in Candida parapsilosis influences the interaction of fungi with epithelial cells 10.1111/j.1567-1364.2007.00223.x 2007
Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis 10.1111/j.1574-6976.2007.00077.x 2007
Self-Aggregation of Cryptococcus neoformans Capsular Glucuronoxylomannan Is Dependent on Divalent Cations 10.1128/EC.00122-07 2007
Gomesin, a peptide produced by the spider Acanthoscurria gomesiana, is a potent anti-cryptococcal agent that acts in synergism with fluconazole 10.1111/j.1574-6968.2007.00850.x 2007
Monoclonal Antibody to Fungal Glucosylceramide Protects Mice against Lethal Cryptococcus neoformans Infection 10.1128/CVI.00202-07 2007
Extracellular Vesicles Produced by Cryptococcus neoformans Contain Protein Components Associated with Virulence 10.1128/EC.00370-07 2007
Binding of the Wheat Germ Lectin to Cryptococcus neoformans Suggests an Association of Chitinlike Structures with Yeast Budding and Capsular Glucuronoxylomannan 10.1128/EC.00307-07 2007
Glucuronoxylomannan-mediated interaction of Cryptococcus neoformans with human alveolar cells results in fungal internalization and host cell damage 10.1016/j.micinf.2005.07.027 2006
Characterization of an ecto-ATPase activity in Fonsecaea pedrosoi 10.1007/s00203-006-0100-1 2006
Vesicular Polysaccharide Export in Cryptococcus neoformans Is a Eukaryotic Solution to the Problem of Fungal Trans-Cell Wall Transport 10.1128/EC.00318-06 2006
An ectophosphatase activity in Cryptococcus neoformans 10.1111/j.1567-1364.2006.00105.x 2006
Exposure of Human Leukemic Cells to Direct Electric Current: Generation of Toxic Compounds Inducing Cell Death by Different Mechanisms 10.1385/CBB:42:1:061 2005
Antimicrobial activity of Croton cajucara Benth linalool-rich essential oil on artificial biofilms and planktonic microorganisms 10.1111/j.1399-302X.2004.00201.x 2005
The multitude of targets for the immune system and drug therapy in the fungal cell wall 10.1016/j.micinf.2005.03.002 2005
Ceramide glycosylation and fatty acid hydroxylation influence serological reactivity in glycosphingolipids 10.1016/j.femsle.2005.01.024 2005
Structure, Cellular Distribution, Antigenicity, and Biological Functions of Fonsecaea pedrosoi Ceramide Monohexosides 10.1128/IAI.73.12.7860-7868.2005 2005
Characterization of an ecto-ATPase activity in 10.1016/j.femsyr.2005.04.005 2005
Antinociceptive and free radical scavenging activities of Cocos nucifera L. (Palmae) husk fiber aqueous extract 10.1016/j.jep.2004.03.013 2004
Differential expression of sialylglycoconjugates and sialidase activity in distinct morphological stages of Fonsecaea pedrosoi 10.1007/s00203-004-0653-9 2004
Melanin from Fonsecaea pedrosoi Induces Production of Human Antifungal Antibodies and Enhances the Antimicrobial Efficacy of Phagocytes 10.1128/IAI.72.1.229-237.2004 2004
Structure and biological functions of fungal cerebrosides 10.1590/S0001-37652004000100007 2004
Glucosylceramides in are involved in the differentiation of conidia into mycelial cells 10.1016/S0014-5793(04)00156-5 2004
A monoclonal antibody to glucosylceramide inhibits the growth of Fonsecaea pedrosoi and enhances the antifungal action of mouse macrophages 10.1016/j.micinf.2004.03.004 2004
Ectophosphatase activity in conidial forms of Fonsecaea pedrosoi is modulated by exogenous phosphate and influences fungal adhesion to mammalian cells 10.1099/mic.0.27405-0 2004
Herpetomonas samuelpessoai: Dimethylsulfoxide-Induced Differentiation Is Influenced by Proteinase Expression 10.1007/s00284-002-3795-5 2003
Cleavage of human fibronectin and other basement membrane-associated proteins by a Cryptococcus neoformans serine proteinase 10.1016/S0882-4010(02)00195-X 2003
Differentiation of Fonsecaea pedrosoi mycelial forms into sclerotic cells is induced by platelet-activating factor 10.1016/j.resmic.2003.09.002 2003
Characterization of glucosylceramides in Pseudallescheria boydii and their involvement in fungal differentiation 10.1093/glycob/12.4.251 2002
Changes of sialomolecules during the dimethylsulfoxide-induced differentiation of Herpetomonas samuelpessoai 10.1007/s00436-002-0685-5 2002
Glycosphingolipids from Magnaporthe grisea cells: expression of a ceramide dihexoside presenting phytosphingosine as the long-chain base 10.1016/S0003-9861(02)00365-X 2002
Sialylglycoconjugates and sialyltransferase activity in the fungus Cryptococcus neoformans 10.1023/A:1024245606607 2002
Local antilaminin antibody treatment alters the rejection pattern of murine cardiac allografts: correlation between cellular infiltration and extracellular matrix1 10.1097/00007890-200212150-00007 2002
Direct current decreases cell viability but not P-glycoprotein expression and function in human multidrug resistant leukemic cells 10.1002/bem.75 2001
Cellular damage and altered carbohydrate expression in P815 tumor cells induced by direct electric current: An in vitro analysis 10.1002/1521-186X(200012)21:8<597::AID-BEM6>3.0.CO;2-Z 2000
Human Antibodies against a Purified Glucosylceramide from Cryptococcus neoformans Inhibit Cell Budding and Fungal Growth 10.1128/IAI.68.12.7049-7060.2000 2000
Pathogenicity of Cryptococcus neoformans: virulence factors and immunological mechanisms 10.1016/S1286-4579(99)80025-2 1999
Identification of N-Acetylneuraminic Acid and Its 9-O-Acetylated Derivative on the Cell Surface of Cryptococcus neoformans: Influence on Fungal Phagocytosis 1997
Eventos:
Nenhum evento cadastrado
Publicações:
Minha Rede: